Nayla Cristina do Vale Moreira

Diabetes Research and Clinical Practice · 2020

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from Nayla Cristina do Vale Moreira's perspective

Ordered by how strongly the researchers Nayla Cristina do Vale Moreira trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
  2. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review (Infectious Diseases of Poverty)
  3. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury (The Lancet)
  4. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status (Military Medical Research)
  5. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
  6. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)
  7. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (New England Journal of Medicine)
  8. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (The Lancet)
  9. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle (Journal of Medical Virology)
  10. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. (Journal of the American Medical Association (JAMA))

Their papers